298987
Evaluation of the success of information disclosure on reducing environmental releases in Louisiana
Methods: Data on the release of known or suspected carcinogens were obtained from the US Environmental Protection Agency’s (EPA) Toxics Release Inventory (TRI). Relative risk scores were calculated using the EPA’s Risk Screening Environmental Indicators (RSEI) model, based the amount of chemical released, chemical toxicity values, and the size of the exposed population. Trends in both the releases and relative risk scores for OSHA carcinogens and cancer-specific carcinogens were evaluated and are presented here.
Results: The RSEI-estimated relative risk scores associated with OSHA carcinogen releases decreased substantially between 1996 and 2011, suggesting that the TRI may have had a positive effect over time on the environmental performance of industry. However, almost half of all facilities reporting between 1996 and 2011 demonstrated an increase in releases and the associated relative risks.
Conclusion: Improvement is not uniform: some facilities have been leaders while others have been laggards. Information disclosure has an important role to play in environmental policy, but only as part of an integrated set of policy tools that includes conventional command and control regulation.
Learning Areas:
Environmental health sciencesPublic health or related laws, regulations, standards, or guidelines
Public health or related public policy
Learning Objectives:
Evaluate TRI reported environmental releases using risk-based methods
Evaluate the success of information disclosure as a policy for increasing industrial environmental performance
Keyword(s): Environmental Health, Policy/Policy Development
Qualified on the content I am responsible for because: I have been the program manager of several state environmental public health programs, and was the principal investigator of a federally funded grant focusing on environmental public health tracking. Among my scientific interests is the association between industrial releases and adverse public health outcomes.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.